Results 161 to 170 of about 7,785,903 (293)
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
A comprehensive approach to users from a Brazilian clinical genetics service: an observational study. [PDF]
de Francisco DD +3 more
europepmc +1 more source
Underrepresentation of the term cerebral palsy in clinical genetics databases. [PDF]
Srivastava S +3 more
europepmc +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
Review Article: Overview of Clinical Genetics of Diabetes Mellitus. [PDF]
Asamoah A, Ahima RS.
europepmc +1 more source
Clinical genetics of spondylocostal dysostosis: A mini review. [PDF]
Umair M +4 more
europepmc +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Current and Future Applications of Artificial Intelligence in Clinical Genetics. [PDF]
Lawrence J.
europepmc +1 more source
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou +4 more
wiley +1 more source
Equity implications of patient-initiated recontact and follow-up in clinical genetics. [PDF]
Mackley MP, Chad L.
europepmc +1 more source

